• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管加压素V(1A)受体第二个细胞内环的活性肽模拟物在结构上与视紫红质第二个细胞内环相关:一项结合1H核磁共振和生化研究

Active peptidic mimics of the second intracellular loop of the V(1A) vasopressin receptor are structurally related to the second intracellular rhodopsin loop: a combined 1H NMR and biochemical study.

作者信息

Déméné Hélène, Granier Sébastien, Muller Dany, Guillon Gilles, Dufour Marie-Noëlle, Delsuc Marc-André, Hibert Marcel, Pascal Robert, Mendre Christiane

机构信息

Centre de Biochimie Structurale, UMR 5048 CNRS-UM1/UMR 554 INSERM-UM1, 29, rue de Navacelles, 34060 Montpellier Cedex, France.

出版信息

Biochemistry. 2003 Jul 15;42(27):8204-13. doi: 10.1021/bi027358n.

DOI:10.1021/bi027358n
PMID:12846569
Abstract

Vasopressin (VP) receptors belong to the widespread G protein-coupled receptor family. The crucial role of VP receptor intracellular loops in the coupling with the heterotrimeric G proteins was previously demonstrated by construction of a vasopressin receptor chimera. Yet, no fine structural data are available concerning the receptor molecular determinants involved in their interactions with G proteins. In this study, we synthesized both a linear and a cyclic form of the second intracellular loop (i2) of the human V(1a) vasopressin receptor isoform that is important for the interaction between the alphaq/alpha11 G protein and the receptor. These two peptides are biologically active. They specifically inhibit vasopressin binding to the V(1a) receptor, suggesting that the corresponding endogenous peptides contribute to the structure of the vasopressin binding site via intra- or intermolecular interactions with the core of the V(1a) receptor. The i2 peptide structures were determined by (1)H NMR. Both exhibit a helix and helical elements in their N- and C-terminal parts, respectively, separated by a turn imposed by a proline residue. More interestingly, the central Pro-Leu motif conserved in many GPCRs and thought to be important for coupling to G proteins can adopt different conformations. The "U" shape structure of the i2 loop is compatible with its anchoring to transmembrane domains III and IV and is very similar to the shape of bovine rhodopsin i2. Altogether, these data contribute to a better understanding of the structure of a not yet crystallized GPCR using the mimetic peptide approach.

摘要

血管加压素(VP)受体属于广泛存在的G蛋白偶联受体家族。先前通过构建血管加压素受体嵌合体证明了VP受体细胞内环在与异源三聚体G蛋白偶联中的关键作用。然而,关于参与其与G蛋白相互作用的受体分子决定因素,尚无精细的结构数据。在本研究中,我们合成了人V(1a)血管加压素受体亚型的第二个细胞内环(i2)的线性和环状形式,该环对于αq/α11 G蛋白与受体之间的相互作用很重要。这两种肽具有生物活性。它们特异性抑制血管加压素与V(1a)受体的结合,表明相应的内源性肽通过与V(1a)受体核心的分子内或分子间相互作用,对血管加压素结合位点的结构有贡献。i2肽的结构通过(1)H NMR确定。两者在其N端和C端部分分别呈现出一个螺旋和螺旋元件,由脯氨酸残基引起的一个转折分隔开。更有趣的是,许多GPCR中保守的中心Pro-Leu基序被认为对与G蛋白偶联很重要,它可以采用不同的构象。i2环的“U”形结构与其锚定到跨膜结构域III和IV是兼容的,并且与牛视紫红质i2的形状非常相似。总之,这些数据有助于使用模拟肽方法更好地理解尚未结晶的GPCR的结构。

相似文献

1
Active peptidic mimics of the second intracellular loop of the V(1A) vasopressin receptor are structurally related to the second intracellular rhodopsin loop: a combined 1H NMR and biochemical study.血管加压素V(1A)受体第二个细胞内环的活性肽模拟物在结构上与视紫红质第二个细胞内环相关:一项结合1H核磁共振和生化研究
Biochemistry. 2003 Jul 15;42(27):8204-13. doi: 10.1021/bi027358n.
2
Structure of the third intracellular loop of the vasopressin V2 receptor and conformational changes upon binding to gC1qR.
J Mol Biol. 2009 May 8;388(3):491-507. doi: 10.1016/j.jmb.2009.02.065. Epub 2009 Mar 12.
3
Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.激动剂诱导的牛视紫红质构象变化:深入了解G蛋白偶联受体的激活
J Mol Biol. 2008 Oct 3;382(2):539-55. doi: 10.1016/j.jmb.2008.06.084. Epub 2008 Jul 7.
4
Structure determination of the fourth cytoplasmic loop and carboxyl terminal domain of bovine rhodopsin.牛视紫红质第四胞质环和羧基末端结构域的结构测定
Mol Vis. 1996 Dec 29;2:12.
5
Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.基于对[脱氨基-半胱氨酸1]精氨酸加压素4位的修饰设计人血管加压素V1b受体的强效和选择性激动剂。
J Med Chem. 2004 Apr 22;47(9):2375-88. doi: 10.1021/jm030611c.
6
Molecular and conformational features of a transport-relevant domain in the C-terminal tail of the vasopressin V(2) receptor.
Mol Pharmacol. 2000 Feb;57(2):232-42.
7
Three dimensional structure of the seventh transmembrane helical domain of the G-protein receptor, rhodopsin.G蛋白偶联受体视紫红质第七跨膜螺旋结构域的三维结构。
Mol Vis. 2000 Jul 27;6:125-31.
8
Coupling interaction between thromboxane A2 receptor and alpha-13 subunit of guanine nucleotide-binding protein.血栓素A2受体与鸟嘌呤核苷酸结合蛋白α-13亚基之间的偶联相互作用。
J Proteome Res. 2005 Sep-Oct;4(5):1681-6. doi: 10.1021/pr050145a.
9
Extracellular loops and ligand binding to a subfamily of Family A G-protein-coupled receptors.细胞外环与A类G蛋白偶联受体亚家族的配体结合。
Biochem Soc Trans. 2007 Aug;35(Pt 4):717-20. doi: 10.1042/BST0350717.
10
Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.负责血管加压素与人神经垂体激素受体结合的相互作用分析——活化受体-血管加压素-G(α)系统的分子动力学研究
J Pept Sci. 2006 Mar;12(3):180-9. doi: 10.1002/psc.714.

引用本文的文献

1
Investigation of interactions at the extracellular loops of the relaxin family peptide receptor 1 (RXFP1).松弛素家族肽受体1(RXFP1)细胞外环相互作用的研究。
J Biol Chem. 2014 Dec 12;289(50):34938-52. doi: 10.1074/jbc.M114.600882. Epub 2014 Oct 28.
2
Lifting the lid on GPCRs: the role of extracellular loops.揭开 G 蛋白偶联受体的“盖子”:细胞外环的作用。
Br J Pharmacol. 2012 Mar;165(6):1688-1703. doi: 10.1111/j.1476-5381.2011.01629.x.
3
Unraveling the structure and function of G protein-coupled receptors through NMR spectroscopy.
通过核磁共振波谱技术揭示 G 蛋白偶联受体的结构与功能。
Curr Pharm Des. 2009;15(35):4003-16. doi: 10.2174/138161209789824803.
4
Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies.用[精氨酸6、D-色氨酸7,9、N-甲基苯丙氨酸8] -P物质(6-11)靶向V1A-血管加压素受体,确定了一种开发新型抗癌疗法的策略。
Br J Pharmacol. 2009 Jan;156(1):36-47. doi: 10.1111/j.1476-5381.2008.00003.x.
5
Solution NMR of signal peptidase, a membrane protein.信号肽酶(一种膜蛋白)的溶液核磁共振研究
Biochim Biophys Acta. 2008 Apr;1778(4):937-44. doi: 10.1016/j.bbamem.2007.11.013. Epub 2007 Dec 14.
6
Studies of the molecular mechanisms of action of relaxin on the adenylyl cyclase signaling system using synthetic peptides derived from the LGR7 relaxin receptor.利用源自LGR7松弛素受体的合成肽对松弛素作用于腺苷酸环化酶信号系统的分子机制进行的研究。
Neurosci Behav Physiol. 2007 Sep;37(7):705-14. doi: 10.1007/s11055-007-0071-y.